Product
Oral Vancomycin
2 clinical trials
5 indications
Indication
Hepatocellular CarcinomaIndication
Pancreatic CancerIndication
Colorectal CancerIndication
Liver MetastasisClinical trial
Phase II Study of Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in Patients With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic CancersStatus: Completed, Estimated PCD: 2022-10-31
Clinical trial
Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant RecipientsStatus: Completed, Estimated PCD: 2023-06-01